Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.
Saraff V, Arango-Sancho P, Bacchetta J, Boot AM, Burren CP, Chinoy A, Dharmaraj P, Gómez Llorente MA, González Rodríguez JD, Gueorguieva I, Hayes W, Schnabel D, Duro HR, Davies EH, Komarzynski S, Rylands AJ, Sandilands K, Ishii H, Williams A, Selveindran S, Barlassina A, Bowden A, Linglart A. Saraff V, et al. Among authors: boot am. Orphanet J Rare Dis. 2026 Feb 3. doi: 10.1186/s13023-026-04244-2. Online ahead of print. Orphanet J Rare Dis. 2026. PMID: 41634723 Free article. No abstract available.
HRQoL in Adolescents with Idiopathic Isolated GHD: rhGH (Dis)continuation in Mid-Puberty.
Vliegenthart J, Busschbach J, Rings EHHM, van den Akker ELT, van der Kaay DCM; SEENEZ Growth Hormone Consortium, Other members of the SEENEZ Growth Hormone Consortium include; Bakker B, Boot AM, de Bruin C, Finken MJJ, van der Heyden JC, Hokken-Koelega ACS, van der Kamp HJ, van Mil EG, Sas TCJ, Schott DA, van Setten PA, Straetemans S, van Tellingen V, Touwslager RNH, Paul van Trotsenburg AS, Voorhoeve PG, Wit JM. Vliegenthart J, et al. Among authors: boot am. Endocr Connect. 2026 Jan 24;15(2):e250843. doi: 10.1530/EC-25-0843. Online ahead of print. Endocr Connect. 2026. PMID: 41586765 Free PMC article.
Growth Hormone Withdrawal in Mid-Puberty: No Impact on Near Adult Height in Adolescents with Transient Idiopathic GHD.
Vliegenthart J, Wit JM, Bakker B, Boot AM, de Bruin C, Finken MJJ, van der Heyden JC, Hokken-Koelega ACS, van der Kamp HJ, van Mil EG, Sas TCJ, Schott DA, van Setten P, Straetemans S, van Tellingen V, Touwslager RNH, van Trotsenburg ASP, Voorhoeve PG, Rings EHHM, van den Akker ELT, van der Kaay DCM. Vliegenthart J, et al. Among authors: boot am. J Clin Endocrinol Metab. 2025 Nov 15:dgaf626. doi: 10.1210/clinem/dgaf626. Online ahead of print. J Clin Endocrinol Metab. 2025. PMID: 41239863
Clinical Characteristics and Response to Growth Hormone Treatment in 27 Children With Heterozygous NPR2 Variants: Real-World Data.
Renes JS, Reedijk AMJ, Hokken-Koelega ACS, Hendriks YMC, Bakker B, Boot AM, van Setten PA, van der Kaay DCM, van Duyvenvoorde HA, Nievelstein RAJ, Losekoot M, de Bruin C. Renes JS, et al. Among authors: boot am. J Clin Endocrinol Metab. 2025 Dec 18;111(1):e166-e174. doi: 10.1210/clinem/dgaf309. J Clin Endocrinol Metab. 2025. PMID: 40424589
Quantified Fluorescence Imaging for the Perfusion of the Parathyroid Glands of Children (FLUOPATCH): A Multicenter, Proof-of-Concept Study.
van de Berg DJ, Schouw HM, Vriens MR, Paul van Trotsenburg AS, Mooij CF, van Santen HM, Terwisscha van Scheltinga SCEJ, Boot AM, Nieveen van Dijkum EJM, Kruijff S, Engelsman AF, Derikx JPM. van de Berg DJ, et al. Among authors: boot am. J Pediatr Surg. 2025 Aug;60(8):162365. doi: 10.1016/j.jpedsurg.2025.162365. Epub 2025 May 12. J Pediatr Surg. 2025. PMID: 40368174 Free article.
Loss-of-Function GHSR Variants Are Associated With Short Stature and Low IGF-I.
Punt LD, Kooijman S, Mutsters NJM, Yue K, van der Kaay DCM, van Tellingen V, Bakker-van Waarde WM, Boot AM, van den Akker ELT, van Boekholt AA, de Groote K, Kruijsen AR, van Nieuwaal-van Maren NHG, Woltering MC, Heijligers M, van der Heyden JC, Bannink EMN, Rinne T, Hannema SE, de Waal WJ, Delemarre LC, Rensen PCN, de Bruin C, van Duyvenvoorde HA, Visser JA, Delhanty PJD, Losekoot M, Wit JM, Joustra SD. Punt LD, et al. Among authors: boot am. J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1303-e1314. doi: 10.1210/clinem/dgaf010. J Clin Endocrinol Metab. 2025. PMID: 39785833 Free PMC article.
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
Boot AM, Ariceta G, Beck-Nielsen SS, Brandi ML, Briot K, Collantes CL, Giannini S, Haffner D, Keen R, Levtchenko E, Mughal MZ, Mӓkitie O, Nilsson O, Schnabel D, Tripto-Shkolnik L, Zillikens MC, Liu J, Tudor A, Emma F. Boot AM, et al. Ther Adv Chronic Dis. 2024 May 18;15:20406223241247643. doi: 10.1177/20406223241247643. eCollection 2024. Ther Adv Chronic Dis. 2024. PMID: 38764445 Free PMC article.
A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH).
Saraff V, Boot AM, Linglart A, Semler O, Harvengt P, Williams A, Bailey KMA, Glen F, Davies EH, Wood S, Greentree S, Rylands AJ. Saraff V, et al. Among authors: boot am. PLoS One. 2024 Jan 19;19(1):e0295080. doi: 10.1371/journal.pone.0295080. eCollection 2024. PLoS One. 2024. PMID: 38241270 Free PMC article.
86 results